Selected article for: "cerebrospinal fluid and current evidence"
Author: Chen, Chien-Chin; Chiang, Pei-Chun; Chen, Tsung-Hsien
Title: The Biosafety and Risk Management in Preparation and Processing of Cerebrospinal Fluid and Other Neurological Specimens With Potential Coronavirus Infection
  • Cord-id: n9jf47u8
  • Document date: 2021_1_20
    • ID: n9jf47u8
    Snippet: The recent outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2, has become a global threat. Due to neurological manifestations presented throughout the coronavirus disease process, the potential involvement of COVID-19 in central nervous system has attracted considerable attention. Notably, the neurologic system could be widely affected, with various complications such as acute cerebrovascular events, encephalitis, Guillain-Barré syndrome,
    Document: The recent outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2, has become a global threat. Due to neurological manifestations presented throughout the coronavirus disease process, the potential involvement of COVID-19 in central nervous system has attracted considerable attention. Notably, the neurologic system could be widely affected, with various complications such as acute cerebrovascular events, encephalitis, Guillain-Barré syndrome, and acute necrotizing hemorrhagic encephalopathy. However, the risk assessment of exposure to potential biohazards in the context of the COVID-19 pandemic has not been clearly clarified regarding the sampling, preparation, and processing neurological specimens. Further risk managements and implantations are seldom discussed either. This article aims to provide current recommendations and evidence-based reviews on biosafety issues of preparation and processing of cerebrospinal fluid and neurological specimens with potential coronavirus infection from the bedside to the laboratory.

    Search related documents:
    Co phrase search for related documents
    • acid amplification technology and acute respiratory syndrome: 1, 2, 3
    • acute myelitis and lumbar puncture: 1
    • acute respiratory and additional method: 1, 2, 3
    • acute respiratory and adequately ventilate: 1
    • acute respiratory and local anesthesia: 1, 2, 3, 4
    • acute respiratory and low risk group intermediate risk: 1, 2
    • acute respiratory and lumbar puncture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory and lysis buffer: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and additional method: 1, 2
    • acute respiratory syndrome and adequately ventilate: 1
    • acute respiratory syndrome and local anesthesia: 1, 2, 3, 4
    • acute respiratory syndrome and low risk group intermediate risk: 1, 2
    • acute respiratory syndrome and lumbar puncture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15